Barclays’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Barclays’s Portfolio SSAA Stock Details SSAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,000	Closed	-$10K	–	5536
2022 Q3	$10K	Hold	1,000	–	–	﹤0.01%	4335
2022 Q2	$10K	Hold	1,000	–	–	﹤0.01%	4653
2022 Q1	$10K	Buy	+1,000	New	+$9.75K	﹤0.01%	4614

Barclays's SSAA Position: Q4 2022 in Review

Barclays sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q4 2022, closing a stake of 1,000 shares — an estimated $10K sold.

Barclays first reported a position in SSAA in Q1 2022 and held it in 3 quarters. The position peaked at $10K in Q3 2022. 0 funds tracked by Wall St. Rank hold SSAA as of Q4 2022.

Barclays reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Barclays sold 1,000 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q4 2022, an estimated $10K.
Barclays first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q1 2022 and held it in 3 quarters.
Barclays's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $10K in Q3 2022.
0 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q4 2022.

Based on Barclays's 13F filing for Q4 2022, filed 13 Feb 2023.